The reduction to just below 5% removes Vanguard Capital Management's obligation to file future 13G amendments for routine changes, but does not signal a material change in investment thesis. Monitor for any further 13G/A filings from Vanguard or other large holders.
Price Chart
Executive Summary
Vanguard Capital Management LLC filed an amended Schedule 13G reporting a 4.98% passive stake in Xeris Biopharma Holdings, Inc., down from 5.0%+ in the prior filing. The stake reduction to just below the 5% threshold is a routine portfolio adjustment by a passive index-oriented manager and carries no activist intent.
Key Financial Metrics
Key Facts
- Vanguard Capital Management LLC filed an amended Schedule 13G on 2026-10-30, reporting beneficial ownership of 9,086,791 shares of Xeris Biopharma Holdings, Inc. common stock.
- The reported stake represents 4.98% of shares outstanding, down from the prior filing (July 2026) where the stake was above 5%.
- The filing certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
- The filing is made under Rule 13d-1(b), confirming passive investor status.
Financial Impact
Stake reduced from above 5% to 4.98%, representing a decrease of approximately 0.02% or more of shares outstanding. No dollar value stated in the filing.
Risk Factors
- No material risks identified from this routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0002100119-26-001642 |
| Document: 0002100119-26-001642-index.html | 0002100119-26-001642 |
| Document: 0002100119-26-001642.txt | 0002100119-26-001642 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | SC 13G/A | $10.55 | awaiting T+20 | awaiting T+20 | $10.71 (+1.56%) |
Oct 14, 2026 18d ago | 8-K | $9.77 | awaiting T+20 | awaiting T+20 | $10.71 (+9.62%) |
Oct 2, 2026 4w ago | Insider Cluster | $10.13 | awaiting T+20 | awaiting T+20 | $10.71 (+5.73%) |
Oct 1, 2026 4w ago | 144 | $9.08 $10.71 | ▲ +17.95% | ▲ +19.76% | $10.71 (+17.95%) |
Sep 9, 2026 7w ago | 8-K | $7.71 $10.11 | ▲ +31.13% | ▲ +29.18% | $10.71 (+38.91%) |
Sep 1, 2026 8w ago | Insider Cluster | $8.58 $9.56 | ▲ +11.42% | ▲ +11.51% | $10.71 (+24.83%) |
Aug 6, 2026 12w ago | 8-K | $7.36 $8.59 | ▲ +16.71% | ▲ +16.11% | $10.71 (+45.52%) |
Aug 4, 2026 12w ago | Insider Cluster | $8.11 $8.58 | ▲ +5.80% | ▲ +6.40% | $10.71 (+32.06%) |
Jul 7, 2026 16w ago | Insider Cluster | $8.67 $8.11 | ▲ +6.46% | ▲ +9.73% | $10.71 (−23.53%) |
Jul 2, 2026 17w ago | 3 | $8.28 $8.42 | ▲ +1.69% | ▲ +2.11% | $10.71 (+29.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers